These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17764815)

  • 21. Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.
    Levac K; Menendez P; Bhatia M
    Exp Hematol; 2005 Nov; 33(11):1417-26. PubMed ID: 16263425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo.
    Sozer S; Ishii T; Fiel MI; Wang J; Wang X; Zhang W; Godbold J; Xu M; Hoffman R
    Blood Cells Mol Dis; 2009; 43(3):304-12. PubMed ID: 19762257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo engraftment potential of clinical hematopoietic grafts.
    Leung W; Ramírez M; Novelli EM; Civin CI
    J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice.
    Noort WA; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S58-60. PubMed ID: 9715891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera.
    Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Camacho L; Fernández-Rodríguez C; Pairet S; Longarón R; Ancochea Á; Senín A; Florensa L; Besses C
    Eur J Haematol; 2015 Mar; 94(3):251-7. PubMed ID: 25082530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of murine JAK2V617F-positive myeloproliferative disease.
    Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
    Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of expression of CXCR4 and adhesion molecules by human CD34+ cells from different sources: role in homing efficiency in NOD/SCID mice.
    Herrera C; Sanchez J; Torres A; Pascual A; Rueda A; Alvarez MA
    Haematologica; 2004 Sep; 89(9):1037-45. PubMed ID: 15377464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
    Lu M; Xia L; Li Y; Wang X; Hoffman R
    Blood; 2014 Jul; 124(5):771-9. PubMed ID: 24869939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea.
    Sirhan S; Lasho TL; Hanson CA; Mesa RA; Pardanani A; Tefferi A
    Am J Hematol; 2008 May; 83(5):363-5. PubMed ID: 18266209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms.
    Wang J; Ishii T; Zhang W; Sozer S; Dai Y; Mascarenhas J; Najfeld V; Zhao ZJ; Hoffman R; Wisch N; Xu M
    Leukemia; 2009 Sep; 23(9):1577-86. PubMed ID: 19387466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intra-bone marrow infusion of human cord blood hematopoietic stem/progenitor cells improves hematopoietic reconstitution in NOD-SCID mice].
    Meng ZT; Gao JT; Lu SH; Yan X; Li YH; Yang Z; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1010-5. PubMed ID: 19698249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
    Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
    Du Z; Wang Z; Zhang W; Cai H; Tan WS
    Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.
    Jetmore A; Plett PA; Tong X; Wolber FM; Breese R; Abonour R; Orschell-Traycoff CM; Srour EF
    Blood; 2002 Mar; 99(5):1585-93. PubMed ID: 11861272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic characterization of malignant progenitor cells in patients with idiopathic myelofibrosis.
    Bao Y; Hu W; Guo Y; Yang W
    Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):146-154. PubMed ID: 30796884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Schiedlmeier B; Kühlcke K; Eckert HG; Baum C; Zeller WJ; Fruehauf S
    Blood; 2000 Feb; 95(4):1237-48. PubMed ID: 10666196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.